Xencor Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Xencor Inc's ROA in the second quarter of 2026?
Xencor Inc recorded a cumulative net loss of $-163 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -20.37%.

However, within the Healthcare sector 362 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3462, from total ROA ranking in the first quarter of 2026 at 3764.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-17.56 %	-18.55 %	28.81 %	29.11 %	25.71 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-163	-172	-92	-132	-172
Return On Assets (TTM)	-20.37 %	-20.51 %	-10.44 %	-15.8 %	-21.92 %
XNCR's Total Ranking	# 3462	# 3764	# 3422	# 3545	# 3687
Total Assets (TTM) in million	725	737	877	869	879
Seq. Total Assets Change	-1.61 %	-15.99 %	0.95 %	-1.21 %	-2.79 %
Seq. Net Income Change	-	-	-	-	-

XNCR's 5 Years Annual ROA >> Back to XNCR Management Effectiveness >> Compare XNCR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 131
Sector	# 363
Overall	# 3431

Return On Assets Statistics
High	Average	Low
16.26 %	-7.27 %	-25.52 %
(Jun 30 2016)		(Dec 31 2024)

Financial Statements
Xencor Inc's Assets	$ 725 million	XNCR's Balance sheet
Xencor Inc's Income	$ -22 million	Quarterly XNCR's Income Statement
XNCR's Income by Division		See XNCR's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	32.88 %	-16.43 %	-2.67 %	61.01 %	-25.83 %
Total Assets in million	875	659	788	810	503
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-92	-237	-133	-55	83
Annual Return On Assets	-10.52 %	-35.9 %	-16.91 %	-6.81 %	16.42 %

XNCR's 5 Years Annual ROA >> Back to XNCR Management Effectiveness >> Compare XNCR ROA to its Competitors

More Return On Assets Ratios
XNCR's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
XNCR's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for XNCR's Competitors
Subscribers only: Roa for Xencor Inc's Suppliers
Subscribers only: Return On Assets for XNCR's Customers

You may also want to know
XNCR's Roi	XNCR's Inventory Turnover Ratio	XNCR's Growth Rates	XNCR's Dividend Comparisons
	XNCR's Profitability Ratios	XNCR's Asset Turnover Ratio	XNCR's Dividend Growth
XNCR's Roe	XNCR's Valuation Ratios	XNCR's Financial Strength Ratios	XNCR's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-10T01:30:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.